5-Amino-1MQ

5-Amino-1MQ is a small molecule compound that blocks an enzyme called NNMT, which stands for nicotinamide N-methyltransferase. This enzyme plays a central role in how your body stores and burns fat. When NNMT activity is high, which happens as you gain excess body fat, your metabolism shifts toward fat storage and away from fat burning. 5-Amino-1MQ inhibits this enzyme, and by doing so, it shifts the balance back in the other direction: your cells become better at burning fat for fuel and your overall energy expenditure increases.

Unlike most other compounds discussed alongside weight loss peptides, 5-Amino-1MQ is not actually a peptide. It is a small molecule, which gives it some practical advantages. Most notably, it survives your digestive system intact and can be taken by mouth with approximately 38% bioavailability, meaning you do not necessarily need to inject it. In the foundational animal studies, mice treated with 5-Amino-1MQ lost significant body fat, about a 35% reduction in white fat tissue, without any reduction in food intake. The fat loss came entirely from increased energy expenditure at the cellular level, making it fundamentally different from GLP-1 drugs that work by suppressing appetite.

It is important to understand who this compound is really for based on the science. The research shows that NNMT overexpression correlates more with excess body fat than with aging. The impressive results came from diet-induced obese mice that already had elevated NNMT creating a metabolic drain. In lean individuals, NNMT is at baseline levels with no dysfunction to correct. If you are already lean and metabolically healthy, there may not be much for this compound to fix. 5-Amino-1MQ is a research compound developed at the University of Texas Medical Branch that has not been approved by the FDA and has limited human clinical data.

To understand 5-Amino-1MQ, picture your cells as engines that convert food into energy. The fuel these engines need is called NAD+, a molecule that is absolutely essential for your mitochondria to produce usable energy. Your body makes NAD+ primarily through something called the salvage pathway, which recycles a form of vitamin B3 called nicotinamide back into NAD+. This recycling process accounts for about 80% of your NAD+ production. But here is the problem: there is a competing pathway driven by the NNMT enzyme that takes that same nicotinamide and converts it into a waste product that gets flushed out of your body.

Under normal circumstances, this is not an issue because both pathways are balanced. But in people with excess body fat, NNMT gets overexpressed specifically in fat tissue. This creates a drain on the one pathway fat cells have for making NAD+. Think of it as a leak in your fuel line: the more fat you carry, the bigger the leak gets, and the less fuel actually reaches your engines. This creates a vicious cycle where obesity increases NNMT, which depletes NAD+ in fat cells, which impairs fat burning and promotes more fat storage, which leads to even more NNMT expression. 5-Amino-1MQ plugs that leak by blocking the NNMT enzyme.

When NNMT is blocked, several beneficial things happen at once. NAD+ levels increase because less nicotinamide is being wasted. SAM, another important cellular resource, is preserved because NNMT is not consuming it. SIRT1, sometimes called a longevity protein, gets activated due to the higher NAD+ levels. Fat cells shrink and new fat creation decreases. And crucially, overall energy expenditure increases without any changes to appetite or food intake. Your cells are simply burning more energy because they have more fuel available. This is why 5-Amino-1MQ is considered complementary to GLP-1 drugs: they reduce how much you eat, while this compound increases how much energy your cells burn.